Srivastava R, Keck B M, Bennett L E, Hosenpud J D
Medical College of Wisconsin, Milwaukee 53215, USA.
Transplantation. 2000 Aug 27;70(4):606-12. doi: 10.1097/00007890-200008270-00013.
It is well established that repeat heart transplantation has a significantly worse outcome when compared with primary (first time) transplantation. Defining the risk factors for mortality within this group has been difficult due to small numbers of patients at individual centers.
All cardiac retransplants performed in the United States and registered in the Joint International Society for Heart and Lung Transplantation (ISHLT)/United Network for Organ Sharing (UNOS) Thoracic Registry were analyzed for demographics, morbidity posttransplantation, immunosuppression, and risk factors for mortality.
The study cohort included 514 patients of which 81% were male with a mean age of 47+/-12 years. Time from primary transplant to retransplantation ranged from 1 day to 15.5 years and more than 50% of the patients underwent retransplantation for chronic rejection. More than 60% of patients were in the intensive care unit at the time of retransplantation and more than 40% of the patients were reported to be on some form of life support (ventricular assist device, ventilator, and/or inotropic therapy). Survival for the entire retransplant cohort was 65, 59, and 55% for 1, 2, and 3 years, respectively, but was substantially lower when the intertransplant interval was short. Conversely, when the interval between primary and retransplantation was more than 2 years, 1 year survival postretransplantation approached that of primary transplantation. Additional independent risk factors for mortality for the retransplant cohort included overall cardiac transplant center volume, the use of a ventricular assist device or ventilator, the patient being in the intensive care unit, and recipient age. The four most common causes of death were infection, primary/nonspecific graft failure, chronic rejection (allograft vasculopathy), and acute rejection.
The data confirm that repeat heart transplantation is a higher risk procedure than primary transplantation, especially early after the primary heart transplant.
与初次(首次)心脏移植相比,再次心脏移植的预后明显更差,这一点已得到充分证实。由于各个中心的患者数量较少,确定该组患者的死亡风险因素一直很困难。
对在美国进行并登记在国际心肺移植学会(ISHLT)/器官共享联合网络(UNOS)胸外科登记处的所有心脏再次移植患者的人口统计学、移植后发病率、免疫抑制情况及死亡风险因素进行分析。
研究队列包括514例患者,其中81%为男性,平均年龄47±12岁。从初次移植到再次移植的时间为1天至15.5年,超过50%的患者因慢性排斥反应接受再次移植。超过60%的患者在再次移植时入住重症监护病房,超过40%的患者使用某种形式的生命支持(心室辅助装置、呼吸机和/或强心治疗)。整个再次移植队列1年、2年和3年的生存率分别为65%、59%和55%,但移植间隔较短时生存率显著降低。相反,当初次移植与再次移植的间隔超过2年时,再次移植后1年生存率接近初次移植。再次移植队列死亡的其他独立风险因素包括心脏移植中心的总体手术量、使用心室辅助装置或呼吸机、患者入住重症监护病房以及受者年龄。四种最常见的死亡原因是感染、原发性/非特异性移植物功能衰竭、慢性排斥反应(同种异体血管病变)和急性排斥反应。
数据证实,再次心脏移植是比初次移植风险更高的手术,尤其是在初次心脏移植后早期。